Skip to main content

Vaccine Manufacturing and Innovation Centre: Investment

Question for Department for Business, Energy and Industrial Strategy

UIN 98277, tabled on 5 January 2022

To ask the Secretary of State for Business, Energy and Industrial Strategy, pursuant to the Answer of 5 January 2022 to Question 94362, how much has the Government invested in the Vaccine Manufacture and Innovation Centre since its inception (a) directly and (b) through its agencies; and what other forms of control does the Government exercise of that Centre.

This answer is the replacement for a previous holding answer.

Answered on

11 January 2022

The Vaccine Manufacturing Innovation Centre (VMIC) UK is a private company, limited by guarantee, and as such the UK Government does not exercise any ownership rights.

VMIC has been granted £206m of Government funding to date to support the delivery of the facility, including grants since the beginning of the COVID-19 pandemic to increase vaccine manufacturing capacity. Reflecting the public funding VMIC has received, UK Research and Innovation (who have been managing the grant on behalf of the Vaccine Taskforce) will be required to ‘consent’ to any sale of the company or its assets and have confirmed that they will work closely with the Vaccine Taskforce in performing this function.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.